Usama Gergis MD MBA

PubMed

• Decentralized CAR-T production: clinical, economic, and regulatory perspectives. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article.
  Abdulrahman Nasiri, Riad El Fakih, Christian Chabannon, Laurent Garderet, Jurgen Kuball
  Bone Marrow Transplantation. 2026-09-24
• Epigenetic Priming with Azacitidine Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies: A Phase II Study.
  Mohammad Alhomoud, Franco Castillo Tokumori, Nora Chokr, Joshua Fein, Daniel C Choi
  Transplantation and Cellular Therapy. 2026-08-15
• Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004.
  William G Wierda, Kathleen A Dorritie, Jordan Gauthier, Rajneesh Nath, Thomas J Kipps
  Blood. 2026-07-28

Journal Articles

• The Addition Of Low Dose Total Body Irradiation To Fludarabine And Melphalan Conditioning In Haplo-Cord Transplantation For High Risk Hematological Malignancies  
  Choe HK, Gergis U, Mayer SA, Nagar H, Phillips AA, Shore TB, Smith MJ, van Besien K, Transplantation, 1/19/2016
• Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and survival free of progression and GVHD (GRFS)  
  Van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman ..., Haematologica, 1/11/2016
• Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors  
  Shanavas M, Popat U, Michaelis LC, Fauble V, McLornan D, Klisovic R, Mascarenhas J, Tamari R, Arcasoy MO, Davies J, Gergis U, Ukaegbu OC, Kamble RT, Storring JM, Majha..., Biol Blood Marrow Transplant, 1/1/2016

Books/Book Chapters

• Maternal Health 
  Chapter: Hematologic Malignancies in Pregnancy 
  Page 513 - 534Usama Gergis, Pinkal Desai, Adriana Rossi, Adrienne PhillipsEditors: Juise D. Pacheco, George R. Saade and Gary D.V. Hankins.McGraw Hill2015

Abstracts/Posters

• Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
  Usama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion
  Usama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...
  Usama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant? 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018